About Martin Dubuc

Martin Dubuc is the Chief Executive Officer at SeqOne Genomics, a French HealthTech startup specializing in AI-powered clinical genomics. The company provides AI-powered software for next-generation sequencing (NGS) data analysis in oncology and rare diseases. Dubuc joined SeqOne's board of directors in October and was appointed CEO in January 2024. Prior to SeqOne Genomics, he headed Biogen’s Global Digital Health division and has over two decades of experience in the pharmaceutical industry at Pfizer, Merck&Co, and Biogen.

Resources Pricing

Resources

Join freeJoin for free Free · no credit card

Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

AI-scored pitch deck
Matched investor list
Personalized outreach drafts

Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

All
Seed & Pre-Seed
Series A & B
Fintech
SaaS & Dev Tools
Consumer & Social
Marketplace & Frontier
Mistakes to Avoid
Checklist
How to Send
Design
Length
Order
Storytelling
Investor Q&A
One-Pager
Email Templates
Data Room
Investor Update
Term Sheet
SAFE vs Priced
Due Diligence
Timeline
Metrics
Valuation
Cap Table
Pipeline
Board
Objections
References
Closing
Bridge Round
Down Round
Secondary Sale
Investor Rejection
First Meeting
Second Meeting
Partner Meeting
Post-Mortem
Update Cadence
Angel Round
Option Pool Shuffle
Fundraise Pause
Vetting VCs
First 90 Days
First Board Meeting
Reference Calls
NDA Template
Bylaws Template

LibraryPitch Deck Examples

Slide-by-slide guide

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

LibraryArticles

•By Alejandro Cremades

Martin Dubuc, Founder of SeqOne Genomics

About Martin Dubuc

Martin Dubuc at a glance

More founders in Paris, France (44)

Browse related founder lists (6)